...
首页> 外文期刊>The Journal of molecular diagnostics: JMD >Highly Multiplex Real-Time PCR-Based Screening for Blood-Borne Pathogens on an OpenArray Platform
【24h】

Highly Multiplex Real-Time PCR-Based Screening for Blood-Borne Pathogens on an OpenArray Platform

机译:基于高度多重实时PCR的OpenArray平台上的血型病原体筛查

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Molecular diagnostics are increasingly used in the blood bank industry. A device that can combine simultaneous detection of multiple targets with the flexibility of inclusion of emerging pathogens is desirable for testing blood products. A highly multiplexed blood-borne pathogen panel (BBPP) using dual-label probe chemistry (TaqMan assays) was developed for simultaneous detection and discrimination of 17 viral pathogens in human plasma samples and 13 bacterial and protozoan pathogens in human blood samples on the OpenArray platform. The custom BBPP OpenArray plate was tested for specificity and analytical sensitivity with purified nucleic acids from each pathogen and with pathogen-spiked human blood and plasma samples. The results of analytical validation of known samples yielded decision trees for identification of coded samples: pathogens spiked in human plasma or whole blood. Results from coded samples demonstrated no false positives among the plasma or whole blood specimens. Samples not detected were at the lower limit of the detectible range or qualified for retesting as indeterminate. Further demonstration of the performance of the BBPP OpenArray was achieved with clinical samples from a blood donor testing organization. Ninety-five percent of virus-positive samples were correctly identified. These results show that a high-throughput OpenArray PCR platform can be expanded and adapted for higher discrimination and newly emerging agents, enabling consideration for development as a next-generation device for testing blood products.
机译:分子诊断越来越多地用于血库行业。可以将同时检测多个靶标的装置与血液产品进行柔韧的装置相结合的装置。使用双标签探针化学(Taqman测定)的高度复用血化病原体面板(BBPP)用于同时检测和辨别人类血浆样品中的17个病毒病原体和在OpenArray平台上的人血样中的13种细菌和原生动物病原体。用来自每种病原体的纯化的核酸和病原体掺入的人血液和血浆样品测试定制BBPP OpenArray板的特异性和分析敏感性。已知样品分析验证的结果产生了决策树,用于鉴定编码样品:病原体掺入人血浆或全血中。编码样品的结果证明了血浆或全血样品之间没有误报。未检测到的样品处于可检测范围的下限,或者有资格用于重新静止。通过来自献血组织的临床样本实现了BBPP Openarray的性能的进一步证明。正确鉴定了百分之九十五的病毒阳性样品。这些结果表明,可以扩展高通量OpenArray PCR平台,适用于更高的识别和新出现的药剂,使得能够考虑开发作为用于测试血液产品的下一代装置。

著录项

  • 来源
  • 作者单位

    Diatherix Labs LLC Dept Res &

    Dev Huntsville AL USA;

    US FDA Div Emerging &

    Transfus Transmitted Dis Ctr Biol Evaluat &

    Res Silver Spring MD USA;

    Thermo Fisher Sci Genet Sci Div San Francisco CA USA;

    Creat Testing Solut Res &

    Dev Support Tempe AZ USA;

    Creat Testing Solut Operat &

    Sci Affairs Tempe AZ USA;

    US FDA Div Emerging &

    Transfus Transmitted Dis Ctr Biol Evaluat &

    Res Silver Spring MD USA;

    US FDA Div Emerging &

    Transfus Transmitted Dis Ctr Biol Evaluat &

    Res Silver Spring MD USA;

    US FDA Div Emerging &

    Transfus Transmitted Dis Ctr Biol Evaluat &

    Res Silver Spring MD USA;

    US FDA Div Emerging &

    Transfus Transmitted Dis Ctr Biol Evaluat &

    Res Silver Spring MD USA;

    US FDA Div Emerging &

    Transfus Transmitted Dis Ctr Biol Evaluat &

    Res Silver Spring MD USA;

    US FDA Div Emerging &

    Transfus Transmitted Dis Ctr Biol Evaluat &

    Res Silver Spring MD USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 临床医学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号